blinded endpoint evaluation
Showing 1 - 25 of >10,000
Ischemic Stroke Trial in Guangzhou (Aspirin, Clopidogrel, Alteplase)
Not yet recruiting
- Ischemic Stroke
- Aspirin
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Jun 11, 2023
Acute Ischemic Stroke Trial (Ginkgo Biloba Extract)
Not yet recruiting
- Acute Ischemic Stroke
- Ginkgo Biloba Extract
- (no location specified)
Nov 20, 2023
Hirayama Disease Trial in New Delhi (Posterior cervical fixation surgery)
Not yet recruiting
- Hirayama Disease
- Posterior cervical fixation surgery
-
New Delhi, Delhi, IndiaDeepti Vibha
Jul 25, 2023
COVID-19 Trial (Recommended treatment schedule, Usual care)
Not yet recruiting
- COVID-19
- Recommended treatment schedule
- Usual care
- (no location specified)
Nov 2, 2022
Acute Ischemic Stroke Trial in Changchun (Urinary kallidinogenase for injection, Guideline-prescribed medical therapy)
Not yet recruiting
- Acute Ischemic Stroke
- Urinary kallidinogenase for injection
- Guideline-prescribed medical therapy
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
Nov 14, 2023
Acute Ischemic Stroke, Functional Outcomes Trial (Human Urinary Kallidinogenase, Clinical Routine Treatment)
Not yet recruiting
- Acute Ischemic Stroke
- Functional Outcomes
- Human Urinary Kallidinogenase
- Clinical Routine Treatment
- (no location specified)
Nov 10, 2023
Stroke, Acute Ischemic Trial in Shenyang (head-down position)
Not yet recruiting
- Stroke, Acute Ischemic
- head-down position
-
Shenyang, ChinaDepartment of Neurology, General Hospital of Northern Theater Co
Aug 23, 2023
Stroke, Ischemic Trial in Shenyang (Tenecteplase)
Not yet recruiting
- Stroke, Ischemic
-
Shenyang, ChinaDepartment of Neurology, General Hospital of Northern Theater Co
Aug 23, 2023
Intracranial Aneurysm, Cerebrovascular Disease Trial in Beijing (Aspirin Enteric-coated Tablets)
Not yet recruiting
- Intracranial Aneurysm
- Cerebrovascular Disease
- Aspirin Enteric-coated Tablets
-
Beijing, Beijing, China
- +1 more
Jun 14, 2023
Coronary Heart Disease Trial in Beijing (Ticagrelor, Clopidogrel, Aspirin)
Not yet recruiting
- Coronary Heart Disease
- Ticagrelor
- +2 more
-
Beijing, Beijing, ChinaFuwai Hospital
Oct 15, 2023
Intracerebral Hemorrhage Basal Ganglia (Diagnosis) Trial (Endoscopic surgery, Medical management)
Not yet recruiting
- Intracerebral Hemorrhage Basal Ganglia (Diagnosis)
- Endoscopic surgery
- Medical management
- (no location specified)
Sep 12, 2022
Mitral Valve Prolapse, Ventricular Arrhythmias and Cardiac Arrest Trial in Oslo (Flecainide, Metoprolol)
Recruiting
- Mitral Valve Prolapse
- Ventricular Arrhythmias and Cardiac Arrest
-
Oslo, NorwayOslo University Hospital Rikshospitalet
Jan 6, 2023
Cerebral Amyloid Angiopathy Trial in Newport Beach, Pasadena (AMDX-2011P)
Not yet recruiting
- Cerebral Amyloid Angiopathy
-
Newport Beach, California
- +1 more
Jan 24, 2023
Basilar Artery Occlusion, Thrombectomy, Tenecteplase Trial (Tenecteplase for Injection, Saline)
Not yet recruiting
- Basilar Artery Occlusion
- +2 more
- Tenecteplase for Injection
- Saline
- (no location specified)
Oct 12, 2022
Pulmonary Arterial Hypertension Trial in Gothenburg (CS1 Administration)
Recruiting
- Pulmonary Arterial Hypertension
- CS1 Administration
-
Gothenburg, SwedenNiklas Bergh
Dec 5, 2022
Acute Ischemic Stroke Trial in Barcelona (Tenecteplase)
Recruiting
- Acute Ischemic Stroke
-
Barcelona, SpainHospital Universitari Vall d'Hebron
Nov 22, 2022
Acute Ischemic Stroke Trial in Aarhus (Semaglutide, Standard care)
Not yet recruiting
- Acute Ischemic Stroke
- Semaglutide
- Standard care
-
Aarhus, DenmarkAarhus University Hospital
Dec 9, 2022
Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism Trial in Detroit (Abelacimab, Dalteparin)
Recruiting
- Venous Thromboembolism
- +2 more
- Abelacimab
- Dalteparin
-
Detroit, MichiganHenry Ford Health System
Jul 18, 2022
Luminal B/HER2-negative Breast Cancer Trial in Hangzhou (Dalpiciclib combined with aromatase inhibitors,
Recruiting
- Luminal B/HER2-negative Breast Cancer
- Dalpiciclib combined with aromatase inhibitors
- anthracycline-cyclophosphamide followed by taxane
-
Hangzhou, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 30, 2022
Breast Cancer, Non Hodgkin Lymphoma Trial in Middlesbrough (Enalapril)
Recruiting
- Breast Cancer
- Non Hodgkin Lymphoma
-
Middlesbrough, Teesside, United KingdomSouth Tees Hospitals NHS FT
Oct 20, 2022
Parkinson Disease, Amyotrophic Lateral Sclerosis Trial in Newport Beach, Pasadena (AMDX2011P)
Recruiting
- Parkinson Disease
- Amyotrophic Lateral Sclerosis
-
Newport Beach, California
- +1 more
Sep 14, 2022
COVID-19 Trial (Recommended treatment schedule, Usual care)
Not yet recruiting
- COVID-19
- Recommended treatment schedule
- Usual care
- (no location specified)
Feb 22, 2022
Traumatic Intracranial Hemorrhage Trial (Timing/1 week, Timing/3 weeks)
Not yet recruiting
- Traumatic Intracranial Hemorrhage
- Timing/1 week
- Timing/3 weeks
- (no location specified)
Sep 29, 2021